Department of Hematology
Hadassah Hospital, Ein Kerem
Jerusalem, Israel.
Dr. Goldfarb was born in Israel.
She studied Medicine at the Hebrew University-Hadassah Medical School, and then went on to her residency in Internal Medicine in the United States at the Beth Israel Division of Mount Sinai Hospital in New York city.
She returned to Israel, where she initially worked in Shaare Zedek Hospital. She did her subspecialty training in hematology at the Mount Scopus Division of Hadassah Hospital, later also working in a research capacity in the Ein Kerem Division in collaboration with the lipid research laboratory, Hadassah Medical Center.
In 1985, Dr. Goldfarb became the staff physician in charge of the Day Care Center, caring with great devotion for patients receiving chemotherapy as well as being the physician in charge of the thalassemia care service.
She still holds this position, which was interrupted by a year (1987-88) at the New England Deaconess Hospital in Boston. During her year abroad, Dr. Goldfarb participated in clinical research projects on the use of IL-2 and interferon in solid tumors and the use of GM-CSF in AIDS.
She received tenure in Hadassah Hospital in 1991. During that year, Dr. Goldfarb was honored with the “OT HAMOFET LAROFE Award”, which is conferred by the Society for Medicine and Law in Israel, for outstanding service above and beyond the call of duty, in recognition of her extreme devotion to her patients.
She rose to the rank of Clinical Senior Lecturer in 1995.
List of Publications
I. Papers in peer-reviewed journals
1. Goldfarb, A., Nitzan, D. and Marmary,
Y.: Changes in the parotid salivary gland of beta-thalassemia patients due to hemosiderin deposits. Int. J. Oral Surg., 12:0 115-119, 1983.
2. Steinitz, M., Tamir, S. and Goldfarb, A.: Human anti-pneumococci antibody produced by an Epstein Barr Virus (EBV) - immortalized cell line. J. Immunology, 132(2): 877-882, 1984.
3. Gorodetsky, R., Goldfarb, A., Dagan, I. and Rachmilewitz, E.A.: Noninvasive analysis of skin iron and zinc levels in b-thalassemia major and intermedia. J. Lab. Clin. Med., 105(1): 44-51, 1985.
4. Oppenheim, A., Katzir, Y., Fibach, E., Goldfarb, A. and Rachmilewitz, E.A.: Hypomethylation of DNA derived from purified human erythroid cells correlates with gene activity of the b-globin cluster. Blood, 66(5): 1202-1207, 1985.
5. Grisaru, D., Goldfarb, A., Gotsman, M.S., Rachmilewitz, E.A. and Hasin, Y.: Deferoxamine improves left ventricular function in b-thalassemia. Arch. Intern. Med., 146:2344-2349, 1986.
6. Oppenheim, A., Karsai, A., Treisman, R., Fibach, E., Treves, A., Goldfarb, A., Maniatis, T., Rachmilewitz, E.A. and Glaser, G.: Beta-thalassemia: Analysis of mRNA precursors of a mutant human globin gene with defective splicing using peripheral blood nucleated red blood cells. Hemoglobin, 10(6): 573-586, 1986.
7. Oppenheim, A., Cohen, S., Goldfarb, A., Katzhendler, J., Deutsch, J. and Rachmilewitz, E.A.: Detection of specific b-globin mutations in Kurdish Jews with b-thalassemia. Hemoglobin, 12(1): 31-38, 1988.
8. Eldor, A., Krausz, Y., Atlan, H., Snyder, D., Goldfarb, A., Hy-Am, E., Rachmilewitz, E.A., Kotze, H.F. and Heyns A. du P.: Platelet Survival in patients with Beta-Thalassamia. Am. J._ Hematol. 32: 94-99, 1989.
9. Birkenfeld, A., Goldfarb, A.W., Rachmilewitz, E.A., Schenker, J.G. and Okon E.: Endometrial glandular haemosiderosis in homozygous beta-thalassaemia. European Journal of Obstetrics & Gynecology and Reproductive Biology 31: 173-178, 1989.
10. Goldfarb, A., Grisaru, D., Gimmon, Z., Okon, E., Lebensart, P. and Rachmilewitz, E.A.: High Incidence of Cholelithiasis in Older Patients with Homozygous Beta Thalassemia. Acta Haematol. 83: 120-122, 1990. (P. 0.899; 45/60; 5;5)
11. Grisaru, D., Rachmilewitz, E.A., Mosseri, M., Gotsman, M.S., Lafair, J.S., Okon, E., Goldfarb, A. and Hasin, Y.: Cardio-pulmonary assessment in beta-thalassemia major. Chest, 98: 1138-1142, 1990.
12. Shapira, Y., Glick, B., Finsterbush, A., Goldfarb, A. and Rosenmann, E.: Myopathological findings in thalassemia major. Eur. Neurol. 30(6): 324-327, 1990.
13. Gorodetsky, R., Loewenthal, E., Goldfarb, A. and Rachmilewitz, E.A.: Non-invasive evaluation of iron load and clearance in patients with beta-thalassemia. Ann. N.Y. Acad. Sci., 612: 568-572, 1990.
14. Rachmilewitz, E.A., Goldfarb, A. and Dover, G.: Administration of erythropoietin to patients with beta thalassemia intermedia - a preliminary trial. Blood, 78(4): 1145-1147, 1991. (P. 8.977; 3/60; 42;42)
15. Eldor, A., Lellouche, F., Goldfarb, A., Rachmilewitz, E.A. and Maclouf, F.: In Vivo Platelet Activation in b Thalassemia Major Reflected by Increased Platelet-Thromboxane Urinary Metabolites. Blood, 77: 1749-1753, 1991. (P. 8.977; 3/60; 32;30)
16. Goldfarb, A., Rachmilewitz, E.A. and Eisenberg, S.: Abnormal low and high density lipoproteins in homozygous beta-thalassemia. Br. J. Haematol. 79: 481-486, 1991.(P. 3.068; 12/60; 10;10)
17. Grinberg, L.N., Shalev, O., Goldfarb, A. and Rachmilewitz, E.A.: Primaquine-induced superoxide production by b-thalassemic red blood cells. Biochim. Biophys. Acta 1139: 248-250. 1992.
18. Landau, H., Matoth, I., Landau-Cordova, Z., Goldfarb, A., Rachmilewitz, E.A. and Glaser, B.: Cross-sectional and longitudinal study of the pituitary-thyroid axis in patients with thalassemia major. Clinical Endocrin., 38: 55-61, 1993.
19. Matzner, Y., Goldfarb, A., Abrahamov, A., Drexler, R., Friedberg, A. and Rachmilewitz, E. A.: Impaired neutrophil chemotaxis in patients with thalassemia major. Br. J. Haematol. 85: 153-158, 1993.
20. Filon, D., Oron, V., Krichevski, S., Shaag, A., Shaag, Y., Warren, T.C., Goldfarb, A., Shneor, Y., Koren, A., Aker, M., Abramov, A., Rachmilewitz, E.A., Rund, D., Kazazian, Jr., H.H. and Oppenheim, A.: Diversity of b-globin mutations in Israeli ethnic groups reflects recent historic events. Am. J. Hum. Genet. 54: 836-843, 1994.
21. Lossos, A., Gomori, J.M., Siegal, T., Libson, E. and Goldfarb, A. Prospective evaluation of spinal epidural extramedullary hematopoiesis (EMH) in asymptomatic thalassemia patients. J. Neurology; 241(51): 123, 1994.
22. Shalev, O., Repka, T., Goldfarb, A., Grinberg, L., Abrahamov, A., Olivieri, N.F., Rachmilewitz, E.A. and Hebbel, R.P.: Deferiprone (L1) chelates pathologic iron deposits from membranes of intact thalassemic and sickle red blood cells both in vitro and in vivo. Blood, 86(5): 2008-2013,_ 1995. (P. 8.988; 3/60; 22;22)
23. Chen, S., Eldor, A., Barshein, G., Zhang, S., Goldfarb, A., Rachmilewitz, E.A. and Yedgar, S.: The enhanced aggregability of red blood cells of b-thalassemia major patients. Am. J. Physiol. 270: H1951-1956, 1996. (P. 3.243; 7/63; 16) (17/76; 11;45)
24. Rund, D., Oron-Karni, V., Filon, D., Goldfarb, A., Rachmilewitz, E.A. and Oppenheim, A.: Genetic analysis of b-Thalassemia Intermedia in Israel: Diversity of mechanisms and unpredict- ability of phenotype. Am. J. Hematol. 54: 16-22, 1997. (P. 1.498; 30/60; 14;14)
25. Ruf, A., Pick, M., Deutsch, V., Patscheke, H., Goldfarb, A., Rachmilewitz, E.A., Guillin, M.C. and Eldor, A.: In-vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with b-thalassemia major. Br. J. Haematol. 98: 51-56, 1997. (P. 3.068; 12/60; 18/16)
26. Rund, D., Fibach, E., Goldfarb, A., Friedberg, A. and Rachmilewitz, E.A.: Heme Arginate Therapy for beta-thalassemia: In vitro versus in vivo Effects. Acta Haematol. 100: 82-84, 1998. (P. 0.899; 45/60; 1;1)
27. Ginsberg, G., Tulchinsky, T., Filon, D., Goldfarb, A., Abramov, E. and Rachmilewitz, E.A. Cost-benefit analysis of a national thalassaemia prevention programme in Israel. J. Med. Screen. 5: 120-126, 1998. (P. 1.986; 18/88; 2;2)
28. Nitzan, M., Schechter, D., Mahler, Y., Goldfarb, A. and Chisin, R.: Pulmonary systolic blood volume increase in thalassemic patients. J. Card. Diag. & Proced. 15(2): 91-99, 1998.
29. Hovav, T., Goldfarb, A., Artmann, G., Yedgar, S. and Barshtein, G. Enhanced Adhesion of b-Thalassemia Erythrocytes to Endothelial Cells. Br. J. Haematol. 106: 178-81, 1999. (P. 3.068; 12/60; 4;4)
30. Eldor, A., Durst, R., Hy-Am, E., Goldfarb, A., Gillis, S., Rachmilewitz, E.A., Abramov, A., Maclouf, J., Godefray, Y.C., de Raucourt, E. and Guillin, M.C.: A chronic hypercoagulable state in patients with b-thalassemia major is already present in childhood. Br. J. Haematol., 107(4): 739-46, 1999. (P. 3.068; 12/60; 2;2)
31. Dresner-Pollak, R., Rachmilewitz, E.A. and Goldfarb, A. Bone Mineral Metabolism in Adult Homozygous b-thalassemia major and intermedia. Br. J. Haematol., 111(3): 902-7, 2000. (P. 3.068; 12/60; 0)
32. Nitzan, D.W., Goldfarb, A., Gati, I. and Kohen, R. Changes in the reducing power of the synovialfluid from Temporomandibular joint presenting “Anchored Disc Phenomenon”. J. Oral Maxillofacial Surg. Accepted for publication - 2002.
33. Altarescu, G., Rodanski, D., Goldfarb, A., Abramov, A., Rund, D., Elstein, D., Zimran, A. Plasma Chitotriosidase Activity in Patients with b-thalassemia. Accepted to American Journal of Hematology, 2002.
Ib) Clinical Observations
1. Kornberg, A., Goldfarb, A. and Shalev, O.: Pseudo-Pelger - Huet Anomaly in Chronic Lymphocytic Leukemia. Acta Haemat., 66: 127-128, 1981.
2. Kornberg, A., Fibach, E., Treves, A., Goldfarb, A. and Rachmilewitz, E.A.: Circulating erythroid progenitors in patients with "spent" polycythaemia vera and myelofibrosis with myeloid metaplasia. Br. J. Haematol., 52: 573-578,_ 1982.
3. Daas, N., Polliack, A., Amir, G., Darman, D., Kleinman, Y., Goldfarb, A. and Ben-Yehuda, D. Kidney involvement and renal manifestations in non-Hodgkin’s lymphoma and lymphocytic leukemia: A retrospective study in 700 patients. Europ. Journal of Haematol. 67: 158-164, 2001.
4. Cohen, Y., Polliack, A., Daas, N., Zelig, O. and Goldfarb, A. Monotherapy with Rituximab induces rapid remission of recurrent cold agglutinin-mediated hemolytic anemia in indolent lympho-plasmacytic lymphoma. Leukemia & Lymphoma 42(6): 1405-1408, 2001.
Id) Reviews, Commentaries, Hypotheses, Editorials
1. Goldfarb, A., Hochner-Celniker, Beller U., Menashe, M. and Palti, Z.: Successful pregnancy in transfusion dependent homozygous beta-thalassemia. Int. J. Gynaecol. Obstet., 20: 319-322, 1982.
2. Shalev, O., Goldfarb, A., Ariel, I. and Rachmilewitz, E.A.:_ Myelofibrosis in young adults. Acta Haematol., 70: 396-399, 1983.
3. Finsterbush, A., Farber, I., Mogele, P. and Goldfarb, A.: Fracture patterns in thalassemia. Clinical Orthopedics and Related Research, 192: 132-136, 1985.
4. Eldor, A., Maclouf, J., Lellouche, F., Ben-Yashar, V., Barenholz, Y., Durst, R., Hy-Am, E., Goldfarb, A. and Rachmilewitz, E.A.: A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. Southeast Asian J. Trop. Med. Public Health, 24: 92-5, 1993.
5. Gillis, S., Cappellini, M.D., Goldfarb, A., Ciceri, L., Fiorelli, G. and Rachmilewitz, E.A. Pulmonary Thromboembolism in Thalassemia Intermedia Patients. Haematologica, 84(10): 959-60, 1999. (P. 2.538; 19/60; 0)
II. Papers in non-peer-reviewed journals
IIa) Original Research Papers
1. Goldfarb, A., Shouval, D., Many, N., Shraga, S. and Rachmilewitz, E.A.: Active vaccination against hepatitis B-virus infection in patients with thalassemia - preliminary results. Harefuah, 111: 273-277, 1986.
2. Manor, D., Fibach, E., Goldfarb, A. and Rachmilewitz, E.A.: Erythropoietin activity in the serum of beta thalassemic patients. Scand. J. Haematol., 37: 221-228, 1986.
3. Grisaru, D., Mosseri, M., Hasin, Y., Goldfarb, A.W., Rachmilewitz, E.A. and Gotsman, M.S.: Mitral valve prolapse is common in beta-thalassemia major. Cardiovascular World Rep. 1: 260-262, 1988
4. Goldfarb, A., Grisaru, D., Gimmon, Z., Okon, E., Lebensart, P. and Rachmilewitz, E.A.: High Incidence of Cholelithiasis in Older Patients with Homozygous Beta Thalassemia. Acta Haematol. 83: 120-122, 1990. (P. 0.899; 45/60; 5;5)
IIb) Clinical Observations
1. Brama, I., Goldfarb, A., Shalev, O. and Ariel, I.: Tumor of the nose as a presenting feature of leukemia. J. Laryngology & Otology, 96: 83-87, 1982.
IId) Reviews, Commentaries, Hypotheses, Editorials
1. Kornberg, A., Ariel, I., Stalnikowitz, R. and Goldfarb, A.: Richter’s Syndrome. Harefuah, November: 210-214, 1981.
2. Finsterbush, A., Goldfarb, A., Ornoy, A., Hawell, A. and Sellay,: Bone fragility in Thalassemia. Elsevier Science Publishers B.V. Current Advances in Skeletogenesis (A. Hawell), 305-310, 1985.
3. Margulies, J.Y., Leichter, I., Goldfarb, A. and Finsterbush, A.: Bone density and bone mineral content of bones in thalassemia major. Proceedings skeletogenesis (A. Ormoi, ed.) Expecta Medica, Amsterdam, 353-354, 1985.
4. Goldfarb, A.W., Stupp-DaCosta, Y., Many, N. and Rachmilewitz, E.A.: Blood transfusions in thalassemia - The Jerusalem Experience. Harefuah, 109: 265-268, 1986.
5. Eldor, A., Maclouf, J., Lellouche, F., Ben-Yashar, V., Barenholz, Y., Durst, R., Hy-Am, E., Goldfarb, A. and Rachmilewitz, E.A.: A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major. Southeast Asian J. Trop. Med. Public Health, 24: 92-5, 1993.
6. Eldor, A., Maclouf, J., Goldfarb, A., Durst, R., Guillin, M.C. and Rachmilewitz, E.A.: A life-long hypercoagulable state in beta-thalassemia major. CRC Reviews, 415-421, 1996.
III. Submitted papers
1. Schechter, D., Yahalom, V., Gimon, Z., Polliack, A., Michelewitz, A., Filon, D. and Goldfarb, A. Chronic indwelling catheter complications in the beta thalassemia patient. Submitted to Am. J. Med. 2002.
2. Koshkaryev, A., Goldfarb, A., Yedgar, S., Barshtein, G. Erythrocytes Adherence to Subendothelial Matrix. Submitted to British Journal of Hematology, 2002.
3. Amer, J., Goldfarb, A. and Fibach, E. Flow Cytometric Measurement of Reactive Oxygen Species (ROS) Production by Normal and Thalassemic Red Blood Cells. Submitted to Free Radical Biology and Medicine, 2002.
Papers in preparation
1. Koshkaryev, A., Goldfarb, A., Yedgar, S., Barshtein, G. Ca++ Dependent Adherence of Erythrocytes to Subenothelial Matrix. In preparation.
2. Goldfarb, A., Barak, V., Dresner-Pollak, R. Cytokines Activity in Adult Homozygous b-thalassemia. In preparation.
3. Breuer, W., Cabantchik, Z. I., Goldfarb, A., Rachmilewitz, E.A, Ben-Yehuda, D. Non-transferrin-Bound Iron (NTBI) in Serum of Adult b-thalassemia Patients. In preparation.
4. Deutsch, V., Rachmilewitz, E.A., Fibach, E., Goldfarb, A., Gillis, S., Terespolsky, N., Eldor, A. Increased Numbers of Circulating CD34+ BFU-E/MK Bipotential Progenitors in Thalassemia Major Patients. In preparation.
IV. List of Abstracts - Published/Presented at Meetings:
1. Korenberg, A., Goldfarb, A., Fibach, E. and Rachmilewitz, E.A. The use of tissue culture of hematopoietic cells in assisting the diagnosis of different hematological disorders. The biannual meeting of the Israel Society of Internal Medicine. March 2nd-3rd, 1981.
2. Goldfarb, A., Korenberg, A. and Ariel, A. Extensive bone marrow necrosis in patients with acute and chronic leukemia. Israel Society of Hematology and Blood Transfusion Meeting, Herzliya. June 23rd, 1981.
3. Steinitz, M., Tamir, S. and Goldfarb, A. Human monoclonal antibodies produced by Epstein-Barr Virus (EBV) immortalized cell lines. 12th Annual Meeting - International Society of Experimental Hematology. Israel. July 1983. (Oral Presentation)
4. Goldfarb, A., Stupp-Dacosta, Y., Manny, N. and Rachmilewitz, E.A. Blood transfusion in thalassemia - the Jerusalem experience. International meeting on blood transfusion in thalassemia: a problem for Italy and the Mediterranean area. Rome. January 30-31, 1984. (Oral Presentation)
5. Margulies, J.Y., Leichter, I., Goldfarb, A. and Finsterbush, A. Measurements of bone density and bone mineral content as a means of prediction of the strength of thalassemic bones. Sixth International Workshop on Calcified Tissues. Kiryat Anavim, Israel, March 18-23, 1984.
6. Gorodetsky, R., Goldfarb, A. and Rachmilewitz, E.A. Non-invasive follow-up of iron deposition and clearance in beta thalassemia. Iron workshop, European Society of Clinical Investigation Meeting, 1984.
7. Hasin, Y., Grisaru, D., Goldfarb, A., Koren, G., Gotsman, M. and Rachmilewitz, E.A. Effects of chelation therapy on the left ventricle of thalassemic patients. 58th Scientific sessions American Heart Association. Circulation 72, Supp. III, October 1985.
8. Maayan, S., Raz, R., Goldfarb, A., Manny, N., Engelhard, D. and Shapira, M. HTLV-3 antibody in thalassemia patients, in Jewish immigrants from Ethiopia and in blood donors in Israel. 5th Medical week in Israel, September 1986.
9. Goldfarb, A., Shouval, D., Manny, N., Shraga, S. and Rachmilewitz, E.A. Active vaccination against hepatitis B virus infection in thalassemia. 5th Medical week in Israel, September 1986. (Oral Presentation)
10. Stater, M., Hiller, N., Goldfarb, A., Linder, N., Schumert, Z. and Rachmilewitz, E.A. Levels of zinc and copper in thalassemia patients. Clinical biochemistry society meeting. Jerusalem, September 1986.
11. Goldfarb, A., Nitzan, D. and Marmany, Y. Change in the parotid salivary gland of beta thalassemia patients due to hemosiderin deposits. Hemoglobin research and application meeting. London, September, 1986. (Oral Presentation)
12. Zipser, Y., Schachar, R., Goldfarb, A., Rachmilewitz, E.A. and Kowoser, N.S. Organization of membrane phospholipids (PL) in beta-thalassemia red cells (thalassemia RBC). 4th International Congress of Cell Biology. August 14-19, 1988. Montreal.
13. Statter, M., Hiller, N., Goldfarb, A., Schumert, Z., Linder, N. and Rachmilewitz, E.A. Zinc status in thalassemia. Seventh International Symposium on trace elements in man and animals. Dubrovnik, May 20-25, 1990.
14. Rachmilewitz, E.A., Goldfarb, A. and Dover, G. Increase in RBC, Hb and Hematocrit following administration of erythropoietin to patients with beta thalassemia intermedia. International Society of Hematology 23rd Congress American Society of Hematology 32nd Annual Meeting, Boston, November 1990.
15. Eldor, A., Lellouche, F., Goldfarb, A., Rachmilewitz, E.A. and Maclouf, J. In vivo platelet activation in beta thalassemia major reflected by increased platelet thromboxane urinary metabolites. International Society of Hematology 23rd Congress American Society of Hematology 32nd Annual Meeting, Boston, November 1990.
16. Gorodetsky, R., Loewenthal, E., Mou, X., Goldfarb, A., Rachmilewitz, E.A. and Gomori, J.M. New approaches for the non-invasive monitoring of iron load in beta thalassemia major. International Congress on Genetic Diseases of Hemoglobin, Nice, France, November 1991.
17. Levene, C., Gekker, K., Poole, J., Goldfarb, A., Dacosta, Y. and Manny, N. Lu 20. A new high incidence antigen and antibody in the lutheran blood group system XXII congen of the International Society of Blood Transfusion. Sao Paulo, Brazil, October 1992.
18. Schechter, D., Goldfarb, A., Gilon, D., Bocher, M., Reim, A., Gottesman, M.S., Rachmilewitz, E.A. and Chisim, R. Right ventricular dysfunction and pulmonary pressure in Beta-thalassemia: An exercise radionuclide ventriculographic and echo doppler correlation. 4th International conference on non-invasive cardiology, Limassol, Cyprus, October 1993.
19. Chen, S., Yedgar, S., Gavish, B., Banstein, G., Goldfarb, A., Rachmilewitz, E.A. and Eldor, A. The hypercoagulable state in Beta-thalassemia major: increased red blood cell aggregation occurs under controlled flow. Blood: (Suppl):1993. Presented at the 35th Annual Meeting of the The American Society of Hematology, St. Louis, Missouri, December 1993.
20. Rund, D., Fibach, E., Goldfarb, A., Friedberg, A. and Rachmilewitz, E.A. Heme arginate therapy for b-thalassemia: in vitro versus in vivo effects. Blood: (Suppl):1996. Presented at the 38th Annual Meeting of the The American Society of Hematology, Orlando, Florida, December 1996.
21. Shalev, O., Choong, S., Goldfarb, A., Abrahamov, A., Rachmilewitz, E.A. and Hebbel, R.P. Deferiprone (L1) attenuates methemoglobin formation in normal (N) and b-thalassemic (T) RBC. Blood: 90(Suppl):1997. Presented at the 39th Annual Meeting of the The American Society of Hematology, San Diego, California, December 5-9, 1997.
22. Shalev, O., Choong, S., Goldfarb, A., Abrahamov, A., Rachmilewitz, E.A. and Hebbel, R.P. Deferiprone (L1) attenuates methemoglobin formation in metabolically-stressed normal (N) and b-thalassemic (T) RBC. Blood: 92(Suppl): 529a, 1998. Presented at the 40th Annual Meeting of the The American Society of Hematology, Miami Beach, Florida, December 4-8, 1998.
23. Goldfarb, A., Rund, D. and Rachmilewitz, E.A. Hydroxyurea ameliorates paraparesis due to extramedullary hematopoiesis and dramatically elevates HgbF in b-thalassemia. EHA European Haematology Association, Barcelona, Spain, June 9-12, 1999.
24. Goldfarb, A., Rachmilewitz, E.A. and Dresner-Pollak, R. Bone Mineral Metabolism in Adult b thalassemia. Blood: 94(Suppl): 423a, 1999. Presented at the 41st Annual Meeting of the The American Society of Hematology, New Orleans, Louisiana, December 3-7, 1999 (Poster).
25. Gillis, S., Salame, S., Goldfarb, A. and Rachmilewitz, E.A. Monocyte tissue-factor expression as the initiator of the hypercoagulable state in thalassemia. Blood: 94(Suppl): 32b, 1999. Presented at the 41st Annual Meeting of the The American Society of Hematology, New Orleans, Louisiana, December 3-7, 1999 (Poster).
26. Deutsch, V., Rachmilewitz, E.A., Fibach, E., Goldfarb, A., Gillis, S., Terespolsky, N. and Eldor, A. Increased Numbers of Circulating CD34+ BFU-E/MK Bipotential Progenitors in Thalassemia Major Patients. ISEH, Tokyo, August 2000 (Poster).
27. Fibach, E., Goldfarb, A. and Amar, J. Flow cytometric measurement of reactive oxygen species (ROS) production by normal and Thalassemic Red Blood Cells. 2001. Presented at the 43rd Annual Meeting of the The American Society of Hematology, Orlando, Florida, December 7-11, 2001.